Skip to content

Insider · CIK 0001752139

Becker Daniel J.

Reports to the SEC for 5 companies · HENDERSON, NV

Transactions

49

Companies

5

Filings

13

CIK

0001752139

Forms 4 and 5

Insider transactions

49 trades
DateCompanyValue
2026-06-17ZURAZura Bio Ltd · Share Option (Right to Buy)A Award—
2025-05-29ZURAZura Bio Ltd · Share Option (Right to Buy)A Award—
2025-05-21ACELYRIN, Inc.D Disposition to Issuer—
2025-05-21ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer—
2025-05-21ACELYRIN, Inc.Director Stock Option (right to buy)D Disposition to Issuer—
2024-07-17ACELYRIN, Inc.S Sale−$6.86
2024-06-07ACELYRIN, Inc.Director Stock Option (right to buy)A Award—
2023-06-22DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award—
2023-05-09ACELYRIN, Inc.Director Stock Option (right to buy)J Other—
2023-05-09ACELYRIN, Inc.Director Stock Option (right to buy)J Other—
2023-05-09ACELYRIN, Inc.P Purchase+$54K
2023-05-04ACELYRIN, Inc.Director Stock Option (right to buy)A Award—
2022-06-21DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award—
2021-06-01DAWNDay One Biopharmaceuticals, Inc.P Purchase+$80K
2021-05-26DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award—
2021-04-01Pandion Therapeutics, Inc.U Disposition from Tender−$170M
2021-04-01Pandion Therapeutics, Inc.U Disposition from Tender−$60K
2021-04-01Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer—
2020-11-19Pandion Therapeutics, Inc.P Purchase+$2.99M
2020-11-18Pandion Therapeutics, Inc.P Purchase+$217K
2020-11-17Pandion Therapeutics, Inc.P Purchase+$201K
2020-11-17Pandion Therapeutics, Inc.P Purchase+$31.7K
2020-09-28Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer—
2020-09-28Principia Biopharma Inc.U Disposition from Tender−$66.8M
2020-09-28Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer—
2020-09-28Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer—
2020-07-21Pandion Therapeutics, Inc.P Purchase+$13M
2020-07-21Pandion Therapeutics, Inc.P Purchase+$18K
2020-07-21Pandion Therapeutics, Inc.Series B Preferred StockC Conversion—
2020-07-21Pandion Therapeutics, Inc.C Conversion—
2020-07-17Pandion Therapeutics, Inc.Stock Option (right to buy)A Award—
2020-06-04Principia Biopharma Inc.Director Stock Option (right to buy)A Award—
2019-11-20Principia Biopharma Inc.P Purchase+$1.65M
2019-10-29Principia Biopharma Inc.P Purchase+$312K
2019-10-28Principia Biopharma Inc.P Purchase+$2.29M
2019-10-18Principia Biopharma Inc.P Purchase+$15M
2019-06-11Principia Biopharma Inc.Director Stock Option (right to buy)A Award—
2018-09-18Principia Biopharma Inc.Series B-3 Convertible Preferred StockC Conversion—
2018-09-18Principia Biopharma Inc.Series C Convertible Preferred StockC Conversion—
2018-09-18Principia Biopharma Inc.P Purchase+$4.59M
2018-09-18Principia Biopharma Inc.C Conversion—
2018-09-18Principia Biopharma Inc.C Conversion—
2018-09-18Principia Biopharma Inc.C Conversion—
2018-09-18Principia Biopharma Inc.C Conversion—
2018-09-18Principia Biopharma Inc.C Conversion—
2018-09-18Principia Biopharma Inc.Series B-1 Convertible Preferred StockC Conversion—
2018-09-18Principia Biopharma Inc.Series B-2 Convertible Preferred StockC Conversion—
2018-09-18Principia Biopharma Inc.Series A Convertible Preferred StockC Conversion—
2018-09-13Principia Biopharma Inc.Director Stock Option (right to buy)A Award—

Recent filings

13